![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Haemonetics’ Plasma-Collection Platform Cleared
Haemonetics’ Plasma-Collection Platform Cleared
October 6, 2020
The FDA has granted 510(k) marketing clearance for Haemonetics’ NexSys plasma-collection system that customizes the collection based on an individual’s body composition.
The clearance, which includes the company’s proprietary Persona technology, was backed by data from a large multicenter trial that showed the collection system yielded a greater average volume of plasma collected per donation.
Plasma-derived medicines are used to treat hundreds of conditions, such as immunodeficiency and hemophilia.
Upcoming Events
-
21Oct